Avian Influenza (Bird Flu): Agricultural and Wildlife Considerations

Last updated December 1, 2011

Definition of Avian Influenza
Agent
Environmental Survival of Avian Influenza Viruses
Hosts
Transmission
Key Outbreaks of HPAI in Domestic Avian Populations
Current Status of H5N1 in Asia, Europe, and Africa
Surveillance for H5N1 in Birds in the United States
HPAI as a Biological Weapon
Clinical Features in Domestic Birds
Necropsy Lesions
Differential Diagnosis in Birds
Laboratory Diagnosis in Birds
Treatment
Prevention
Outbreak Control in Poultry
References

Definition of Avian Influenza

Avian influenza, which is caused by influenza A viruses, can affect a variety of domestic and wild bird species. Infection can range from asymptomatic to severe, depending on the virulence of the virus and the susceptibility of the avian host. Avian influenza in domestic chickens and turkeys is classified according to disease severity, with two recognized forms: highly pathogenic avian influenza (HPAI), also known as fowl plague, and low-pathogenic avian influenza (LPAI). Avian influenza viruses that cause HPAI are highly virulent and mortality rates in infected flocks often approach 100%. While LPAI viruses are generally of lower virulence, LPAI in flocks should be controlled because LPAI viruses can serve as progenitors to HPAI viruses.

Notifiable avian influenza is defined by the World Organization for Animal Health (OIE) as "an infection of poultry caused by any influenza A virus of the H5 or H7 subtypes or by any avian influenza virus with an intravenous pathogenicity index (IVPI) greater than 1.2 (or as an alternative at least 75% mortality)" (see References: OIE 2008). The OIE further classifies avian influenza as HPAI or LPAI according to the following criteria:

HPAI viruses have an IVPI in 6-week-old chickens greater than 1.2 or, as an alternative, cause at least 75% mortality in 4-to 8-week-old chickens infected intravenously. H5 and H7 viruses that do not have an IVPI of greater than 1.2 or cause less than 75% mortality in an intravenous lethality test should be sequenced to determine whether multiple basic amino acids are present at the cleavage site of the hemagglutinin molecule; if the amino acid motif is similar to that observed for other HPAI isolates, the isolate being tested should be considered as HPAI.
LPAI are all influenza A viruses of H5 and H7 subtype that are not HPAI viruses.

According to the OIE Terrestrial Animal Health Code, countries that identify HPAI should report the occurrence to OIE within 24 hours.

Several different avian influenza strains have been shown to infect humans. These include viruses of the H5 subtype (H5N1), the H7 subtype (H7N2, H7N3, H7N7), the H9 subtype (H9N2), and the H10 subtype (H10N7). See the document, "Avian Influenza (Bird Flu): Implications for Human Disease" on this Web site for more information.

Agent

Viral Classification and Genetic Composition of Influenza Viruses

Family: Orthomyxoviridae

Enveloped virions are 80 to 120 nm in diameter, are 200 to 300 nm long, and may be filamentous.
They consist of spike-shaped surface proteins, a partially host-derived lipid-rich envelope, and matrix (M) proteins surrounding a helical segmented nucleocapsid (6 to 8 segments).
The family contains five genera, classified by variations in nucleoprotein (NP and M) antigens: influenza A, influenza B, influenza C, thogotovirus, and isavirus.

Genus: Influenzavirus A

Consists of a single species: influenza A virus.
The multipartite genome is encapsidated, with each segment in a separate nucleocapsid. Eight different segments of negative-sense single-stranded RNA are present; this allows for genetic reassortment in single cells infected with more than one virus and may result in multiple strains that are different from the initial ones (see References: Voyles 2002).
The genome consists of 10 genes encoding for different proteins (eight structural proteins and two nonstructural proteins). These include the following: three transcriptases (PB2, PB1, and PA), two surface glycoproteins (hemagglutinin [HA] and neuraminidase [NA]), two matrix proteins (M1 and M2), one nucleocapsid protein (NP), and two nonstructural proteins (NS1 and NS2).
The virus envelope glycoproteins (HA and NA) are distributed evenly over the virion surface, forming characteristic spike-shaped structures. Antigenic variation in these proteins is used as part of the influenza A virus subtype definition (but not used for influenza B or C viruses).

Influenza A virus subtypes

There are 16 different HA antigens (H1 to H16) and nine different NA antigens (N1 to N9) for influenza A. Until recently, 15 HA types had been recognized, but a new type (H16) was isolated from black-headed gulls caught in Sweden and the Netherlands in 1999 and reported in the literature in 2005 (see References: Fouchier 2005).

H5 subtypes

H5 subtypes include both HPAI and LPAI strains.
H5N1 strains circulate among birds worldwide and are responsible for the current panzootic among domestic poultry and other birds in Asia, Europe, the Middle East, and Africa.
Genetic characterization of H5N1 strains involved in the current panzootic has demonstrated two distinct phylogenetic clades (clades 1 and 2) (see References: Webster 2006; WHO Global Influenza Program Surveillance Network; WHO: Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as human vaccines). Six different subclades of clade 2 have been recognized; three of these are primarily responsible for recent human H5N1 cases.

Clade 1 viruses have circulated primarily in Cambodia, Thailand, Hong Kong, and Vietnam.
Clade 2.1 viruses have circulated primarily in Indonesia.
Clade 2.2 viruses have a wide geographic distribution and have spread to over 60 countries in Asia, the Middle East, Europe, and Africa.
Clade 2.3 viruses are genetically diverse and continue to circulate in birds in Asia. Viruses from this group have caused illness in humans in China, Lao People's Democratic Republic (PDR), Myanmar, and Vietnam.

A study involving genetic characterization of two H5N1 strains suggests that the NS1 gene is critical for pathogenicity of avian influenza in chickens (see References: Li 2006).

H7 and H9 subtypes

H7 includes HPAI and LPAI strains.
H9 is only known to include LPAI strains. H9N2 viruses had been isolated in multiple avian species throughout Asia, the Middle East, Europe, and Africa.
These subtypes have caused infections in humans on rare occasions (see References: CDC: Avian influenza A viruses; WHO: H5N1 avian influenza: timeline of major events). A recent report, however, suggests that human infections with H9N2 viruses may be more common than previously recognized (see References: Wan 2008). The authors also concluded that H9N2 viruses can evolve extensively and reassort, suggesting that they may be capable of undergoing further adaptation for more efficient transmission among mammals and humans.

Influenza A nomenclature

Antigenic strain nomenclature is based on: (1) host of origin (if other than human), (2) geographic origin, (3) strain number, (4) year of isolation, and (5) HA and NA types (eg, for human strains, A/Hong Kong/03/68[H3N2], A/swine/Iowa/15/30[H1N1]).
As with other influenza A subtypes, standard nomenclature is used to name avian strains (eg, A/Chicken/HK/5/98 [H5N1]).

Environmental Survival of Avian Influenza Viruses

Influenza viruses remain infectious after 24 to 48 hours on nonporous environmental surfaces and less than 12 hours on porous surfaces (see References: Bean 1982). (Note: The importance of fomites in disease transmission has not been determined.)
Influenza A viruses can persist for extended periods of time in water (see References: WHO: Review of latest available evidence on risks to human health through potential transmission of avian influenza [H5N1] through water and sewage). One study of subtype H3N6 found that virus resuspended in Mississippi River water was detected for up to 32 days at 4°C and was undetectable after 4 days at 22°C (see References: Webster 1978). Another study found that several avian influenza viruses persisted in distilled water for 207 days at 17°C and 102 days at 28°C (see References: Stallknecht 1990).
One report suggests that influenza A viruses can be preserved in lake ice and then released when the ice thaws the following spring or, in the case of arctic ice, up to years later. This may lead to temporal gene flow between viruses entrapped during one year and those shed by migrating birds in following years (see References: Zhang 2006). This report, however, has been called into question by other investigators who believe, on the basis of a rigorous phylogenetic analysis of the gene sequences for the "ice viruses," that the findings are the result of laboratory contamination of the ice samples with a reference strain (see References: Worobey 2008).
Data from studies of H5N1 in domestic ducks have shown that H5N1 can survive in the environment for 6 days at 37°C (see References: WHO 2004: Laboratory study of H5N1 viruses in domestic ducks: main findings).
A recent report has found that the pH, temperature, and salinity in natural aquatic habitats can influence the ability of avian influenza viruses to remain infective within such environments (see References: Brown 2009).
Inactivation of the virus occurs under the following conditions (see ReferencesReferences: OIE 2002, PHS):

Temperatures of 56°C for 3 hours or 60°C or more for 30 minutes
Acidic conditions
Presence of oxidizing agents such as sodium dodecyl sulfate, lipid solvents, and B-propiolactone
Exposure to disinfectants: formalin, iodine compounds

Hosts

Avian influenza A viruses can infect a variety of domestic and wild avian species (including chickens, turkeys, ducks, domestic geese, quail, pheasants, partridge, parrots, gulls, shorebirds, seabirds, emu, eagles, and others). The clinical manifestation of infection in birds ranges from asymptomatic infection to rapidly fatal disease (see References: Horimoto 2001).

Aquatic Birds

Ducks, shore birds, and gulls are considered the natural reservoirs for avian influenza viruses (see References: Fouchier 2004; Webster 1992). These waterfowl generally do not develop disease when infected with avian influenza viruses (see References: Horimoto 2001); however, H5N1 appears to be virulent for a variety of wild bird species.

An outbreak of H5N1 among migratory geese and other wild birds in Qinghai province, China, was identified in May 2005 (see References: Chen 2005; Liu 2005).
An outbreak in wild swans occurred in Azerbaijan in February 2006, and severe illness from H5N1 influenza has been recognized in a variety of other wild bird species (see References: Gilsdorf 2006; Olsen 2006; USGS National Wildlife Health Center: List of species affected by H5N1 influenza).
North American wood ducks and laughing gulls are susceptible to illness and death from highly pathogenic H5N1 avian influenza viruses (see References: Brown 2006).

Domestic Birds

Domestic chickens and turkeys are susceptible to severe and potentially fatal influenza A caused by HPAI strains. Over the past several years, numerous H5N1 outbreaks have been recognized in chickens and an H5N1 outbreak in turkeys was identified in 2005 (see Oct 13, 2005, CIDRAP News story). Investigators in Asia showed that asymptomatically infected domestic ducks shed more H5N1 virus for longer periods in 2004 than in 2003, which may be a factor in amplifying the spread of H5N1 to domestic poultry (see References: FAO/OIE/WHO 2004).

Other Avian Species

H5N1 infection has also been reported in other avian species.

Another report demonstrated the presence of H5N1 influenza virus in asymptomatic eagles that were smuggled from Thailand into Belgium in 2004 (see References: Borm 2005).
HPAI H5N1 viruses were isolated from asymptomatic tree sparrows in the Henan province of China in 2005 (see References: Kou 2005).

Mammals

Influenza A viruses have traditionally been known to cause disease in horses, pigs, whales, and seals; however, the range of several influenza A subtypes is expanding to different mammalian species.
H5N1 influenza A has now been shown to infect cats, leopards, tigers, civets, and dogs (see References: European Centre for Disease Prevention and Control Influenza Team 2006: H5N1 infections in cats; Keawcharoen 2004; Songserm 2006: Fatal avian influenza A H5N1 in a dog; Songserm 2006: Avian influenza H5N1 in naturally infected domestic cat; Thanawongnuwech 2005; Webster 2006; Yingst 2006).

Some experts are concerned that domestic cats could play a role in transmission of H5N1 to humans, although this has not been documented to date (see References: Kuiken 2006). Asymptomatic infection has been reported in domestic cats (see References: Leschnik 2007), and the Food and Agriculture Organization of the United Nations (FAO) recommends that avian influenza in cats should be closely monitored (see References: FAO: 2007).
A report involving cats experimentally infected with H5N1 demonstrated that infected cats excreted the virus via the respiratory tract and the digestive tract, suggesting that in addition to the respiratory route, other routes of transmission may play a role in spread among mammalian hosts (see References: Rimmelzwaan 2006).
Cat-to-cat transmission of H5N1 can occur (see References: WHO 2006: Influenza research at the human and animal interface).

H5N1 was identified in pigs in China in 2001 and 2003 (see References: Cyranoski 2004). The virus also was found in pigs in Indonesia in 2005 when 5 of 10 pigs tested in western Java were shown to be asymptomatically infected (see References: Cyranoski 2005) and again in 2006 on the Indonesian island of Bali (see Oct 10, 2006, CIDRAP New story). A recent laboratory study, however, found that domestic pigs have low susceptibility to H5N1 viruses; experimental inoculation resulted in asymptomatic infection or mild symptomatic infection limited to the respiratory tract and tonsils (see References: Lipatov 2008).
H5N1 recently has been isolated from an infected mink and a stone marten in Europe (see References: WHO 2006: Influenza research at the human and animal interface).
A study demonstrated that calves can be experimentally infected with H5N1 virus (see References: Kalthoff 2008).
A recent report found that raccoons can become infected with avian and human influenza A viruses, shed and transmit virus to virus-free animals, and seroconvert (see References: Hall 2008).
Red foxes have been shown to be susceptible to H5N1 infection when fed infected bird carcasses (see References: Reperant 2008).
Cases of canine influenza caused by H3N8 have been recognized in the United States in recent years; this subtype traditionally has been found in horses (see References: Crawford 2005, Yoon 2005).

Transmission

Routes of bird-to-bird transmission include:

Airborne transmission if birds are in close proximity
Direct contact with contaminated respiratory secretions or fecal material

Vertical transmission is not known to occur
Other factors that contribute to spread within and between flocks include the following:

Broken contaminated eggs in incubators infecting healthy chicks (see References: OIE 2002)
Movement of infected birds between flocks
Movement of fomites such as contaminated equipment, egg flats, feed trucks, and clothing and shoes of employees and service crews (see References: USDA: Avian influenza; Swayne 2008)
Contact with infected wild birds and waterfowl
Fecal contamination of drinking water
Garbage flies (suspected of transmitting the virus during the 1983-1984 epidemic in Pennsylvania) (see References: Swayne 2008)

The disease is highly contagious. One gram of contaminated manure can contain enough HPAI virus to infect 1 million birds (see ReferencesReferences: USDA: Avian influenza).

Key Outbreaks of HPAI in Domestic Avian Populations

To date, all outbreaks of HPAI in domestic poultry have been caused by H5 or H7 influenza A subtypes. Until 1999, HPAI was considered relatively rare, with only 17 outbreaks reported worldwide between 1959 and 1998; however, since 1999 the number of outbreaks occurring globally has increased significantly (see References: Capua 2004). Major outbreaks of avian influenza are highlighted in the table below.

Major Outbreaks of Avian Influenza in Domestic Poultry^a
Year	Subtype	Location	Impact	Comments
1983	H5	Pennsylvania	Caused severe clinical disease and high mortality rates in chickens, turkeys, and guinea fowl. 17 million birds were culled.	A serologically identical but apparently mild virus had been circulating in poultry in the area for 6 mo (see References: Swayne 2008). No human cases were identified.
1994-2003	H5N2	Mexico	Nearly a billion birds have been affected.	An LPAI virus mutated to an HPAI virus and caused an outbreak in 1994-1995. The H5N2 strain has continued to circulate in Mexico since that time. No human cases have been identified.
1995-2003	H7N3	Pakistan	About 3.2 million birds died from avian influenza during initial outbreak in 1995.	A vaccination campaign apparently ended the outbreak. No human cases were identified.
1997	H5N1	Hong Kong	Virus was isolated from chickens; avian mortality rates were high. 1.5 million birds were culled in 3 days.	18 human cases with 6 deaths were recognized. Prior to this outbreak, H5N1 was not known to infect humans.
2003	H7N7	The Netherlands	30 million birds out of 100 million birds in country were killed; 255 flocks were infected. Disease spread to Belgium but was quite rapidly contained.	Over 80 human cases were reported, and one veterinarian died (see References: Fouchier 2004, Stegeman 2004). Most of the human cases involved conjunctivitis.
2003-2011 (ongoing)	H5N1	Asia, Europe, Africa	Panzootic avian influenza, with outbreaks occurring in many countries around the globe. By August 2006, an estimated 220 million birds had died or been culled (see References: FAO 2006: Caucasus, Balkans at high risk for deadly H5N1 virus).	Over 570 human cases have been recognized, with more than half of them fatal, in Azerbaijan, Bangladesh, Cambodia, China, Djibouti, Egypt, Indonesia, Iraq, Lao People's Democratic Republic, Myanmar, Nigeria, Pakistan, Thailand, Turkey, and Vietnam.
2004	H7N3	British Columbia	Over 19 million birds were culled.	Two human cases were recognized; both patients had conjunctivitis.
2005	H7	North Korea	About 200,000 birds were culled.	No human cases were identified.
^aAdditional outbreaks of HPAI have been identified in a variety of countries. Adapted from Capua 2004 (see References).

Examples of additional outbreaks of avian influenza that have occurred in the past include the following (see References: Horimoto 2001, Capua 2004):

Australia had outbreaks of HPAI in 1976 (H7N7), 1985 (H7N7), 1992 (H7N3), 1994 (H7N3), and 1997 (H7N4).
Italy had outbreaks in 1997 (H5N2), 1998 (H5N9), 1999-2001 (H7N1), and 2003-2003 (H7N3).
The Republic of Ireland had an outbreak in 1998 (H7N7) that spread into Northern Ireland as well.

Since 2002, three outbreaks of HPAI have occurred in the Western hemisphere:

Chile (H7N3) in 2002
United States (H5N2) in 2004
Canada (H7N3) in 2004 (noted in the table above [British Columbia])

In each of these outbreaks, a precursor virus of low pathogenicity mutated to become highly pathogenic after circulating in poultry (see References: Senne 2006).

Current Status of H5N1 in Asia, Europe, and Africa

Avian influenza caused by H5N1 first received widespread recognition following a 1997 outbreak in poultry in Hong Kong with subsequent spread of the virus to humans. During that outbreak, 18 human cases were recognized; six patients died. The outbreak was stopped when all of the domestic chickens present in wholesale facilities and vendors in Hong Kong were slaughtered (see References: Snacken 1999). Person-to-person transmission of H5N1 was not recognized at that time (see References: Uyeki 2002). A precursor to the 1997 H5N1 strain was identified in Guangdong, China, in 1996, when it caused deaths in geese (see References: Webster 2006).

A panzootic of HPAI caused by H5N1 avian influenza started in Asia in the fall of 2003 and spread in domestic poultry farms at an historically unprecedented rate. Outbreaks tapered off in spring 2004 but in summer re-emerged in several countries in Asia (including Cambodia, China, Lao People's Democratic Republic (PDR), Thailand, and Vietnam), where H5N1 avian influenza activity is ongoing. The H5N1 strains currently causing outbreaks across Asia are genetically distinct from the strain isolated from humans in Hong Kong in 1997.

Despite a compulsory poultry vaccination program in China, outbreaks of H5N1 avian influenza have continued to occur in that country. Ongoing market surveillance demonstrates that a single H5N1 sublineage (Fujian [FJ]-like) has emerged as the predominant strain in poultry in China since late 2005 (see References: Smith 2006). Viruses of the FJ-like sublineage belong to genotype Z, which has been the predominant H5N1 genotype in Southern China since 2002.

In the summer of 2005, H5N1 began expanding its geographic range beyond Asia; this trend has continued.

In late July 2005, outbreaks of H5N1 in poultry were recognized in Russia, Kazakhstan, and Mongolia (see References: WHO 2005: Geographical spread of H5N1 avian influenza in birds).
In October 2005, H5N1 spread to Turkey and Europe, and numerous areas in Europe and the Middle East have been affected since (see table below). The pattern of virus activity in Sweden and Denmark in 2006 involved deaths of small numbers of birds (usually singleton birds) in late winter just before the spring migration rather than large die-offs; these findings have implications for H5N1 avian surveillance in Europe and other parts of the world (see References: Komar 2008).
In February 2006, H5N1 was confirmed in a commercial poultry flock in northern Nigeria (see References: WHO: Avian influenza: situation [birds] in Nigeria), marking the first reports of the disease in poultry in Africa. Several other African nations have been affected since then (see table below).
In March 2007, H5N1 was detected for the first time in Bangladesh (see References: FAO 2007).

Reasons for the Spread of H5N1

The spread of H5N1 appears to be related to two factors: spread through movement of poultry (legal as well as illegal) and spread through wild migratory birds (see References: FAO 2006: Should wild birds now be considered a permanent reservoir of the virus?; Liu 2005; Webster 2006). The current perspective is that wild birds may serve as the vector to transport H5N1 from infected areas to new geographic locations and then poultry amplify the virus to create the massive viral loads associated with outbreaks (see References: FAO 2006: Evolution of highly pathogenic avian influenza type H5N1 in Europe: review of disease ecology, trends, and perspectives of spread autumn-winter 2006).

Domestic ducks and geese are considered to be the true vectors of disease transmission in poultry, and according to WHO, mallard ducks are regarded as the "champion" vectors for geographic spread (see References: WHO 2006: Influenza 2006: Influenza research at the human and animal interface).

Studies have shown that until 2002, ducks predominantly shed H5N1 virus in the feces. More recent studies have found that ducks now shed the virus mainly via the respiratory tract, which demonstrates an evolution of the virus and may impact transmission (see References: WHO 2006: Influenza research at the human and animal interface).
Free-grazing ducks have been shown to be a critical factor in persistence and spread of H5N1 in Thailand (see References: Gilbert 2006). Free-ranging backyard chickens, illegal transportation of domestic birds, and cockfighting also have been shown to contribute to spread of the virus in that country (see References: Tiensin 2005).

An assessment of the risk of infection with H5N1 among chickens in Hong Kong during the first quarter of 2002 found that retail marketing of live poultry was the main source of exposure to infection on chicken farms during this period (see References: Kung 2002).
In most of the European countries where H5N1 has been detected, the virus has been associated with introduction through wild migratory birds (see References: FAO 2006: Should wild birds now be considered a permanent reservoir of the virus?; Shestopalov 2006). A recent study showed that the spread of H5N1 from Siberia to the Black Sea basin is consistent in time and space with the migratory patterns of Anatidae species (ducks, geese, and swans) (see References: Gilbert 2006).
In Africa, it appears that the virus has spread predominantly through trade of poultry for human consumption (see References: FAO 2006: Should wild birds now be considered a permanent reservoir of the virus?).
Studies suggest that H5N1 can move from poultry to migratory birds and back again (ie, "relay transmission"), which may account for some of the continuing geographic spread (see References: WHO 2006: Influenza research at the human and animal interface).
An investigation of an H5N1 poultry outbreak that occurred in January 2007 in Great Britain suggests that contaminated turkey meat from Hungary may have been the source of the outbreak (see References: DEFRA 2007). The meat was imported and then further processed at a plant in Great Britain; the plant was in close proximity to a poultry farm.
Among the nine probable sources of infection for avian influenza outbreaks in Bangladesh, egg trays and contaminated vehicles from larger live bird markets and local live bird markets accounted for 47% of probable virus sources, eggs for 48%, and apparently healthy chickens for 5% (see References: Biswas 2008).

Genetic Studies

A 2006 study of H5N1 isolates in Southeast Asia indicates that the lineage originated in southern China and spread to other areas of Southeast Asia through poultry and wild birds. Genetically and antigenically distinct sublineages have emerged in different geographic regions of Southeast Asia, indicating long-term regional endemicity of the virus (see References: Chen 2006).
One genetic study showed that three different sublineages were independently introduced into Nigeria through routes that coincide with flight paths of migratory birds, although the authors state that independent trade imports could not be ruled out as the source of spread (see References: Ducatez 2006). Another study found that isolates from Nigeria were closely related to isolates from West Africa and Sudan; the authors reported that the spread of primary outbreaks appeared to be related to trade (legal and illegal), live bird markets, inappropriate disposal, and poorly implemented control measures (see References: Fasina 2008).
A study that integrated data on phylogenetic relationships of viral isolates, migratory bird movements, and trade in poultry and wild birds determined the pathways of 52 introduction events into various countries (see References: Kilpatrick 2006). Investigators found that 9 of 21 introductions into Asian countries were most likely through poultry and 3 of 21 were through migratory birds. Conversely, in Europe, 20 of 23 introductions were likely through migratory birds. Of 8 introductions into African countries, 2 were likely caused by poultry and 3 by migratory birds. The authors suggest that the spread of H5N1 into the Western Hemisphere is more likely to occur from poultry introductions than from wild birds.
Another phylogeographic study suggests that the Chinese province of Guangdong is the source of multiple H5N1 strains spreading at both regional and international scales (see References: Wallace 2007). Southeast Asia appears to be a regional “sink,” demonstrating bidirectional dispersal among localities within the region. H5N1 appears to be able to infect repeated cycles of host species across localities, regardless of the host species first infected in each locale.
A phylogenetic investigation of outbreaks in Kuwait during 2007 found that virus isolates were most closely related to isolates from central Asia and were likely vectored by migratory birds (see References: Al-Azemi 2008).
Another study found that two different sub-lineages of H5N1 were circulating in Sweden in 2006; one was closely related to isolates of Egyptian, Italian, Slovenian, and Nigerian origin, and the other was closely related to contemporary German and Danish isolates (see References: Kiss 2008).
A report from Nigeria showed that HPAI H5N1 viruses initially imported into Nigeria in 2006 have been gradually replaced by various reassortments. If the high prevalence of reassortants was typical for West Africa in 2007, the absence of such reassortants anywhere else suggests that reintroductions of influenza A (H5N1) from Africa into Eurasia must be rare (see References: Owoade 2008).
Phylogenetic analysis of an H5N1 isolate in Bangladesh found that the isolate was most closely related to viruses isolated from Afghanistan, Mongolia, and Russia (see References: Biswas 2008).

Areas Affected by H5N1 Avian Influenza

Areas affected by H5N1 avian influenza in poultry or migratory birds as of February 2010 are shown in the following table.

Countries Affected by H5N1 in Poultry and Wild Birds as of February 2010
East Asia, Southeast Asia	Europe	Siberia, Central Asia, Middle East	Africa
Cambodia China Hong Kong Indonesia Japan Lao PDR Malaysia Myanmar Mongolia South Korea Thailand Vietnam	Albania Austria Bosnia-Herzegovina Bulgaria Croatia Czech Republic Denmark England France Germany Greece Hungary Italy Poland Romania Russia (European Russia) Scotland Serbia Slovakia Slovenia Spain Sweden Switzerland	Afghanistan Azerbaijan Bangladesh Bhutan Cyprus Georgia India Iran Iraq Israel Jordan Kazakhstan Kuwait Nepal Pakistan Turkey Ukraine Russia (Siberia) Saudi Arabia West Bank and Gaza Strip	Benin Burkina Faso Cameroon Djibouti Egypt Ghana Ivory Coast Niger Nigeria Sudan Togo

Currently, Vietnam, Egypt, and Indonesia are considered by FAO to be countries that are endemic for H5N1 in domestic poultry (see References: FAO 2008: H5N1 HPAI global overview).

Features of H5N1 that raise concern about pandemic potential include the following (see References: WHO Influenza pandemic preparedness and response [January 2005]):

Studies comparing virus samples over time indicate that the virus has become progressively more pathogenic for poultry.
The current strains of the virus are now able to survive several days longer in the environment compared with when it first emerged.
The virus appears to be expanding its mammalian host range, as indicated in the section above on "Hosts."
The virus has been found increasingly in dead migratory birds (which are usually not clinically affected by HPAI viruses); this supports the growing virulence of the current virus.
Genetic sequencing performed on viral isolates from Turkey demonstrated that the strains contain two mutations which may make the virus better adapted to humans (see References: Butler 2006). These mutations could potentially enhance transmission from birds to humans and between humans.
According to a July 2008 report from FAO, H5N1 pathogenicity in birds seems to be rising gradually in Vietnam, as evidenced by more severe respiratory tract infection in ducks and an increase in cloacal virus titers (see References: FAO 2008: Vietnam: H5N1 HPAI pathogenicity rising, but situation in check). These changes involve clades 2.3.2 and 2.3.4 (which presumably are imported from China) as well as the clade 1 virus that has prevailed in the Mekong Delta since early 2004.

In addition to the rapid spread of H5N1 in poultry, over 570 human cases of H5N1 influenza have been confirmed, with more than 320 of them fatal, according to official WHO data (see References: WHO: Cumulative confirmed cases of human H5N1 avian influenza). Influenza experts are concerned that if the H5N1 virus reassorts with human influenza viruses, a new influenza virus with pandemic potential could emerge (see References: Stohr 2005; Monto 2005; WHO: Influenza pandemic preparedness and response [January 2005]). Another possibility is for an avian strain to gradually adapt to the human population and develop into a pandemic strain without genetic reassortment (see References: Taubenberger 2005). For a pandemic to occur, the new virus would need to be highly pathogenic for humans and easily transmitted person-to-person. For more information, see the documents "Avian Influenza (Bird Flu): Implications for Human Disease" and "Pandemic Influenza" on this Web site.

Surveillance for H5N1 in Birds in the United States

To date, HPAI H5N1 has not been detected in the Western hemisphere; however, an introduction via wild migratory birds is possible. Three pathways of interhemispheric migration have been recognized (see References: Rappole 2006):

Alaska—East Asia (birds that breed in Alaska winter in East Asia)
East Asia—Pacific North America (birds that breed in northeast Asia winter along the Pacific coast of North America)
Europe—Atlantic North America (birds that breed in Iceland or Northwestern Europe winter along the Atlantic Coast of North America)

In response to a potential introduction of H5N1 via wild birds, surveillance in the United States aimed at early detection was initiated in Alaska in the spring of 2006 (the National HPAI Early Detection Data System [HEDDS]) and then expanded to the rest of the country during the summer months.

Testing results are being posted on the US Geological Survey (USGS) Web site (see References: USGS National Wildlife Health Center: National HPAI Early Detection Data System [HEDDS]).
No birds with highly pathogenic H5N1 have been detected through the HEDDS surveillance program since testing began in 2006 despite testing of thousands of birds each year. Low-pathogenic avian influenza H5 strains, however, have been isolated from wild birds in a number of states, including Delaware, Illinois, Maryland, Michigan, Missouri, Montana, New York, Ohio, Pennsylvania, and South Dakota. Up-to-date information is available on the HEDDS Web site (see References: APHIS Web site; USGS National Wildlife Health Center: National HPAI Early Detection Data System [HEDDS]).

A recent study of shorebirds sampled during peak spring migration at Hartney Bay, Cordova, Alaska, showed that influenza A virus infection was rare among the birds tested (see References: Winker 2008). Of 1,820 fresh fecal samples screened, only one yielded an avian influenza virus (H16N?).

Another possible mechanism for introduction of H5N1 into the Western hemisphere (and perhaps more likely than an introduction through wild migratory birds) is the import of infected domestic or pet birds (see References: Rappole 2006). A combination of imported poultry and spread via migratory birds could result in introduction of the virus to the United States. For example, infected poultry imported into Canada, Brazil, or Mexico could serve as a source of infection for migratory birds, which could then spread the virus along the various flyways into the United States (see References: Kilpatrick 2006).

HPAI as a Biological Weapon

HPAI is considered a potential biological weapon because of the following factors:

Extremely contagious
High mortality rate
Severe economic consequences of an outbreak:

Large numbers of birds are destroyed or die.
Control measures disrupt trade of poultry products from affected areas.
Prices of retail poultry products may increase significantly.

Virus has a high potential for genetic mutations and for new strains to arise and affect new species

The Hong Kong epidemic of 1997 and the associated human cases demonstrate the ability of the virus to affect humans and birds.

Clinical Features in Domestic Birds

The clinical signs of HPAI are severe and result in high mortality rates in many species of birds, especially domestic fowl. As mentioned above, waterfowl, ratites, and other birds may not be as susceptible to clinical signs but can act as carriers for the virus.

Clinical Features of Highly Pathogenic Avian Influenza in Domestic Birds
Feature	Characteristics
CHICKENS
Incubation Period	3-7 days
Clinical signs	—Sudden death —Severe depression with ruffled feathers —Inappetence —Drastic decline in egg production —Edema of head and neck (see References: Swayne 2008, fig 5D, p 441]) —Swollen and cyanotic combs and wattles (see References: Swayne 2008, fig 5A, 5B, p 441]) —Petechial hemorrhages on internal membrane surfaces —Excessive thirst —Watery diarrhea that begins as bright green and progresses to white —Swollen and congested conjunctiva with occasional hemorrhage —Diffuse hemorrhage between hocks and feet (see Gray Book figure 27 [References: Swayne 2008]) —Respiratory signs are dependent on tracheal involvement —Nasal and ocular discharge —Mucus accumulation (varies) —Lack of energy —Coughing/sneezing —Incoordination —Nervous system signs such as paralysis
Complications	—Cessation of egg production, and eggs laid immediately prior to infection often soft-shelled and misshapen —Surviving birds are in poor condition and resume laying only after a period of several weeks
Case-fatality rate	—Can be as high as 100% —Death may occur prior to any symptoms or as late as a week after symptoms, though it is frequently within 48 hr
TURKEYS
Incubation period	3-7 days
Clinical signs	—Sudden death —Severe depression with ruffled feathers —Inappetence —Drastic decline in egg production —Edema of the head and neck —Swollen and cyanotic combs and wattles —Petechial hemorrhages on internal membrane surfaces —Excessive thirst and evidence of dehydration —Watery diarrhea that begins as bright green and progresses to white —Swollen and congested conjunctivae with occasional hemorrhage —Diffuse hemorrhage between hocks and feet —Respiratory signs are dependent on tracheal involvement —Nasal and ocular discharge —Mucus accumulation (varies) —Lack of energy —Coughing/sneezing —Incoordination —Nervous system signs such as paralysis —Sinusitis —Dehydration
Complications	—Decrease in egg production —Sudden death —Surviving birds are in poor condition and resume laying only after a period of several weeks
Case-fatality rate	—Can be as high as 100% —Most turkeys die within 3 to 10 days
DUCKS AND GEESE
Incubation period	3-7 days
Clinical signs	—Signs of depression, inappetence, and diarrhea similar to those seen in layers —Swollen sinuses —Neurologic signs in younger birds —Sinusitis
Complications	—Decrease in egg production —Sudden death —Surviving birds are in poor condition and resume laying only after a period of several weeks
Case-fatality rate	As high as 100%
Adapted from Kahn 2008; Swayne 2008; Capua 2001; OIE 2002; PHS; USDA: Avian influenza (see References).

Necropsy Lesions

HPAI can be recognized by the high mortality rate in affected flocks as well as by the clinical signs. Characteristic necropsy lesions, listed in the table below, also can help make the diagnosis.

Lesions Associated With Highly Pathogenic Avian Influenza in Birds
Type of Bird	Characteristics
Chickens	Lesions may be absent in young birds and birds that die from peracute disease Severe congestion of musculature Severe congestion of conjunctivae, sometimes with petechiae Excessive mucous exudates in lumen of trachea Severe hemorrhagic tracheitis Petechiae on inside of sternum Petechiae on serosal and abdominal fat and in body cavity Severe kidney congestion, sometimes with urate deposits in tubules Hemorrhages on mucosal surface of proventriculus, especially at juncture with gizzard Hemorrhages and erosions of gizzard lining Hemorrhagic foci on lymphoid tissues in intestinal mucosa Ovary may be hemorrhagic or degenerated with darkened areas of necrosis Peritoneal cavity often filled with yolk from ruptured ova
Turkeys	Lesions similar to those in chickens but may not be as severe
Domestic ducks	Lesions may be similar to those seen in chickens though not as marked, or they may be absent altogether
Adapted from Swayne 2008, OIE 2002 (see References).

Differential Diagnosis in Birds

Other diseases to consider when examining birds suspected of having HPAI include:

Velogenic (exotic) Newcastle disease
Infectious laryngotracheitis
Acute Escherichia coli infections
Acute fowl cholera (Pasteurella multocida)
Bacterial sinusitis (ducks)

Laboratory Diagnosis in Birds

Sample Collection

According to the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (see References), considerations for sample collection for avian influenza in birds include the following:

Samples taken from dead birds should include intestinal contents (feces) or cloacal swabs and oropharyngeal swabs. Samples from trachea, lungs, air sacs, intestine, spleen, kidney, brain, liver, and heart may also be collected and processed either separately or as a pool.
Samples from live birds should include both tracheal and cloacal swabs, although the latter are most likely to yield virus. Because small, delicate birds may be harmed by swabbing, the collection of fresh feces may serve as an adequate alternative. To optimize the chances of virus isolation, it is recommended that at least 1 gm of feces be processed either as feces or coating the swab.
A recent report suggests that feathers may be considered useful samples for surveillance or diagnostic examination of avian influenza virus H5N1 in domestic ducks (see References: Yamamoto 2008).
The samples should be placed in isotonic phosphate buffered saline (PBS), pH 7.0 to 7.4, containing antibiotics.

The antibiotics can be varied according to local conditions, but could be, for example, penicillin (2,000 units/mL), streptomycin (2 mg/mL), gentamicin (50 mcg/mL) and mycostatin (1,000 units/mL) for tissues and tracheal swabs but at five-fold higher concentrations for feces and cloacal swabs. It is important to readjust the solution to pH 7.0 to 7.4 after addition of antibiotics.
Feces and finely minced tissues should be prepared as 10% to 20% (w/v) suspensions in the antibiotic solution. Suspensions should be processed as soon as possible after incubation for 1 to 2 hours at room temperature.

When immediate processing is impractical, samples may be stored at 4°C for up to 4 days. For prolonged storage, diagnostic samples and isolates should be kept at 80°C.

Identification of the Agent

Once specimens have been collected and processed, the OIE Manual recommends the following for identification of avian influenza (see References: OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals):

The preferred method of growing avian influenza A viruses is by the inoculation of embryonated specific pathogen free (SPF) fowl eggs, or specific antibody negative (SAN) eggs of 9 to 11 days' incubation.

Eggs should be incubated at 35°C to 37°C for 4 to 7 days.
Eggs containing dead or dying embryos as they arise, and all eggs remaining at the end of the incubation period, should first be chilled to 4°C and the allantoic fluids should then be tested for hemagglutination (HA) activity.

Detection of HA activity indicates a high probability of the presence of an influenza A virus or of an avian paramyxovirus. Fluids that give a negative reaction should be passaged into at least one further batch of eggs.
Several methods are available to confirm the presence of influenza A virus; these include:

Agar gel immunodiffusion (AGID) tests that demonstrate the presence of the nucleocapsid or matrix antigens
Various enzyme-linked immunosorbent assays (ELISAs)
Reverse-transcription polymerase chain reaction (RT-PCR) using nucleoprotein-specific or matrix-specific conserved primers; the presence of subtype H5 or H7 influenza virus can be confirmed by using H5- or H7-specific primers

Serologic Tests

Because sera from infected chickens can yield positive antibody tests as early as 3 to 4 days after the first signs of disease appear, serologic tests can be useful to diagnose the disease. Examples of serologic tests are outlined below (see References: OIE 2008: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals).

AGID

These tests have been widely and routinely used to detect specific antibodies in chicken and turkey flocks as an indication of infection.
They have generally employed nucleocapsid-enriched preparations made from the chorioallantoic membranes of embryonated fowl eggs that have been infected at 10 days of age, homogenized, freeze/thawed three times, and centrifuged.
The supernatant fluids are inactivated by the addition of 0.1% formalin or 1% betapropiolactone, recentrifuged and used as antigen. Not all avian species may produce precipitating antibodies following infection with influenzaviruses.
Concentrated virus preparations contain both matrix and nucleocapsid antigens; the matrix antigen diffuses more rapidly than the nucleocapsid antigen.

Hemagglutination (HA) and hemagglutination-inhibition (HI) tests

Variations in the procedures for HA and HI tests are practiced in different laboratories and are described in the OIE manual.

Neuraminidase-inhibition test

This test has been used to identify the avian influenza neuraminidase type of isolates and to characterize the antibody in infected birds.
The procedure requires specialized expertise and reagents; consequently this testing is usually done in an OIE Reference Laboratory.

Commercial ELISA kits

These detect antibody against the nucleocapsid protein.
Several different test and antigen preparation methods are in use.
Such tests have usually been evaluated and validated by the manufacturer, and it is therefore important that the instructions specified for their use be followed carefully.

Developing Techniques for the Diagnosis

In addition to the tests mentioned above, new diagnostics have become available in recent years, including:

Antigen detection tests

The commercially available Directigen Flu A Kit (Becton Dickinson Microbiology Systems), which is an antigen-capture enzyme immunoassay system, has been used for detecting the presence of influenza A viruses in poultry, particularly in the United States. The kit uses a monoclonal antibody against the nucleoprotein and should therefore be able to detect any influenza A virus.
The main advantage of the test is that it can demonstrate the presence of avian influenza within 15 minutes.
The disadvantages are that it may lack sensitivity, it has not been validated for different species of birds, subtype identification is not achieved, and the kits are expensive.

Direct RNA detection

RT-PCR techniques on clinical specimens could, with the correctly defined primers, result in rapid detection and subtype (at least H5 and H7) identification.
Direct RT-PCR tests may be useful for rapidly identifying subsequent outbreaks in flocks once the primary infected premises has been identified and the virus characterized.

Treatment

There is no effective treatment for HPAI in poultry.

Prevention

Accepted methods for prevention of avian influenza are outlined below. In response to the situation in Asia, several short-term strategies were put forth by the international health agencies at a meeting in Malaysia in July 2005 (see References: FAO/OIE/WHO July 2005). WHO and FAO issued a statement outlining a multipronged approach that includes:

Educational efforts focusing on small-scale and backyard farms, where most cases of human cases of H5N1 have occurred
Segregation of different animal species (eg, chickens, ducks, pigs) and elimination of these animals' intermingling with humans
Incentives for farmers to report suspected cases of avian flu and to apply control measures
Vaccination of poultry flocks

In August 2005, OIE reiterated this approach, calling for intensification of the measures in view of the spread of H5N1 in late summer 2005 into Russia and Kazakhstan and urging financial support from wealthy nations (see References: OIE: Evolution of the animal health situation with regard to avian influenza 2005).

In response to the ongoing global panzootic, FAO released in March 2006 a proposal for a global control and eradication program (see References: FAO 2006: Avian influenza control and eradication: FAO's proposal for a global programme) that focuses on the following activities:

Coordinate (in collaboration with OIE) the international response at the global and regional levels.
Provide support to infected countries in their efforts to control and eradicate the disease.
Assist at-risk countries in their efforts to be prepared to face an incursion of the disease.
Provide support to newly infected countries.

Enhanced Biosecurity

Traditionally, the best way to prevent HPAI from spreading has been to prevent exposure of flocks to the influenza virus. This depends on the formation of a barrier between farms and the outside environment. Although this approach is still considered the cornerstone for prevention, recent experience has shown that maintaining high enough biosecurity standards to prevent spread is challenging. Strategies to enhance biosecurity include the following (see References: USDA: Avian influenza; FAO 2004):

Avoid contact between domestic poultry and wild birds, especially waterfowl.

Open-range operations have a greater risk of acquiring influenza virus in regions where migratory waterfowl, sea birds, and shore birds are found.
Exclude wild waterfowl from ponds that serve as drinking water for poultry.
If wild waterfowl cannot be excluded from ponds, then drinking water obtained from these sources should be treated (eg, with ultraviolet radiation or chlorination).

Avoid the introduction of birds of unknown disease status into a flock.
Control human traffic.

Ensure that people with access to the flock wear proper safety equipment such as boots, coveralls, gloves, face masks, and headgear.
Provide clean clothing and disinfection facilities for employees.

Follow proper cleaning and disinfection procedures.
Use an "all-in/all-out" production system.
Permit only essential workers and vehicles to enter the farm.
Thoroughly clean and disinfect equipment and vehicles entering and leaving the farm; the tires and undercarriage of vehicles should be included in the process.
Do not loan or borrow equipment or vehicles from other farms.
Avoid visiting other poultry farms. If unavoidable or if visiting a live-bird market, change footwear and clothing before working with your own flock
Do not bring birds from slaughter channels, especially live-bird markets, back to the farm.

Following outbreaks of H5N1 in backyard poultry in rural Cambodia, viral RNA was detected in 27 (35%) of 77 specimens of mud, pond water, water plants, and soil swabs. These results suggest environmental persistence of the virus and underscore the need for regular disinfection of poultry areas (see References: Vong 2008).

Analyses of viral genetic sequences from recent H5N1 outbreaks in Thailand support the concept that viruses re-emerge from a small pool of indigenous sources where they survive the inter-outbreak season and are silently perpetuated over the dry summer months. Results suggest that eradication of H5N1 avian influenza could be accomplished by eliminating the local reservoirs (see References: Chaichoune 2008).

Live Market Practices

The 1997 HPAI outbreak in Hong Kong demonstrated the difficulties of preventing spread of influenza virus in live markets. Once the virus is established in such a market, it can easily spread via the movement of birds, crates, or trucks to other farms and/or markets. It is important to follow biosecurity protocols at live-bird markets as well as on the farm (see References: USDA: Avian influenza).

Use plastic instead of wooden crates for easier cleaning.
Keep scales and floors clean of manure, feathers, and other debris.
Clean and disinfect all equipment, crates, and vehicles before returning them to the farm.
Keep incoming poultry separate from unsold birds, especially if birds are from different lots.
Clean and disinfect the marketplace after every day of sale.
Do not return unsold birds to the farm.

In July 2008, government officials in Hong Kong banned live poultry from overnight stays in market stalls and retail outlets (see Jun 30, 2008, CIDRAP News story). The ban requires live poultry sellers to cull any live birds that remain in stalls or shops at the end of each day. Also during the summer of 2008, Hong Kong instituted a buyout of market poultry vendors to reduce the sale of live birds in that area (see Jul 25, 2008, CIDRAP News story).

Vaccination

Vaccinated birds are less likely to become infected and are less likely to excrete the virus; therefore, vaccination can be used either as a tool to support eradication or as a tool to control the disease and reduce the viral load in the environment. FAO has described three broad categories of vaccination strategies (see References: FAO 2004):

Vaccination in response to an outbreak using a "ring vaccination" approach or vaccination of only designated high-risk poultry; this approach should be used in conjunction with culling of infected poultry.
Vaccination in response to a "trigger," such as evidence from surveillance information that a HPAI virus has entered the area: this approach may be used in situations where the potential to improve biosecurity is limited.
Preemptive baseline vaccination, such as vaccinating poultry during restocking of farms in previously infected areas.

Two different types of vaccines are currently available, both of which are administered by injection (see References: FAO 2004):

Conventional vaccines, which include inactivated homologous vaccines and inactivated heterologous vaccines

They involve an inactivated whole avian influenza virus antigen in oil-based emulsion adjuvant
These vaccines use a homologous H determinant (such as H5 for the strain currently circulating in Asia).
They possess either a homologous (such as N1 for the strain currently circulating in Asia) or heterologous N determinant.
The use of a heterologous N determinant allows use of serologic surveillance to detect the circulation of field virus through the detection of antibodies to the N subtype of the field virus; this is known as the DIVA approach (ie, differentiating infected from vaccinated animals).
The DIVA approach was used successfully during an LPAI outbreak in Italy.

Recombinant vaccines

Several recombinant fowlpox virus-vector vaccines that express the H5 antigen have been developed.
One vaccine has been licensed and is in use in Mexico. However, some experts have questioned whether extensive use of this vaccine resulted in the emergence of antigenic variants that have persisted in the region (see References: Capua 2006, Lee 2004, Webster 2006).
Two studies reported success with experimental recombinant poultry vaccines made with HPAI and Newcastle disease viruses; one of them allows serologic discrimination between vaccinated and field-infected birds (see References: Park 2006, Veits 2006).
Another study involving a recombinant fowlpox-virus vector vaccine found that priming ducks with the fowlpox-virus vaccine and then boosting them with an inactivated vaccine induced optimal immunity against H5N1 and minimal viral replication after challenge (see References: Steensels 2008).

A number of additional novel vaccines either have been developed or are under development. Examples include:

Subunit vaccines
DNA vaccines
Vaccines based on reverse genetics
Adenovirus-vectored vaccine delivered via drinking water
Newcastle disease-vectored vaccine delivered via aerosol
Newcastle disease virus–based bivalent live attenuated vaccine developed through reverse genetics (protects against both Newcastle disease and H5N1 avian influenza) (see References: Ge 2007)

Debate continues over the advisability of widespread poultry vaccination in preventing the current spread of H5N1. Imperfectly implemented vaccination programs have the potential to actually impede control of the disease (see References: Capua 2006, European Centre for Disease Surveillance and Control Influenza Team 2006, Webster 2006).

An acceptable vaccination program should decrease the level of virus excretion among vaccinated birds below the level of transmissibility. In addition, unvaccinated sentinel birds should be kept on the premises to monitor for viral shedding, antigenic drift, or both. To date, the only system that enables detection of exposure and has resulted in eradication is the DIVA system (outlined above under the section on vaccination), although new vaccines are showing promise (see References: Capua 2006).
A poor vaccination program can promote undetected spread of the virus by preventing disease signs but not reducing the level of viral excretion below transmissible levels.
It is not clear whether large-scale poultry vaccination would ultimately decrease or increase the risk of human exposure to H5N1. In addition, poorly implemented vaccination programs may mask infection in poultry, thereby decreasing initiation of early surveillance for human disease in areas where human exposure is likely to occur.
Compulsory vaccination of poultry in China has not stopped the spread of H5N1 in that country. The vaccine used in China apparently generates very low neutralizing antibodies to FJ-like H5N1 strains (which is now the predominant sublineage circulating in poultry in China). Use of the vaccine may actually have promoted the selection of this particular variant through "immune escape" from the vaccine (see References: Smith 2006).
Compulsory vaccination of poultry also was introduced in Vietnam in 2005. Although vaccination may have contributed to a decline in H5N1 activity in 2005 and most of 2006, the virus resurfaced in Vietnam late in 2006 (see December 20, 2006, CIDRAP News Story).

Outbreak Control in Poultry

Several steps should be taken to control an outbreak of HPAI (see References: FAO 2004):

Controlled movement of birds and products that may contain virus

Infected "zones" should be identified, and movement of items and birds from those zones should be controlled.
Border controls should be instituted as necessary.

Destruction of infected and at-risk poultry ("stamping out")

This should be done as humanely and as quickly as possible, preferably within 24 hours after infection in the flock is detected.
One widely used method is asphyxiation using carbon dioxide.
Stringent cleaning and disinfection of the facilities and equipment should be performed after culling.
No new birds should be allowed in facilities for at least 21 days after depopulation and disinfection.
According to an article following a 2003 H7N7 outbreak in the Netherlands, complete depopulation of infected areas seemed to be the most effective control measure (see References: Stegeman 2005). However, when the HPAI strain becomes endemic (as in the current situation in Asia with H5N1), efforts to eradicate the virus from poultry in affected areas are likely to be less effective.
Although "stamping out" is advocated as a primary outbreak control measure, the extensiveness of the current H5N1 panzootic has led to concerns about the impact of mass culling of millions of birds on local and regional economies and on the ability to maintain food security in poor areas of the world (see References: Capua 2006).

Proper disposal of carcasses and all animal products in contact with the infected flock should be performed in a biosecure and environmentally acceptable manner.
Vaccination of flocks may be suitable for control in some situations or may be used as an adjunct to mass culling efforts (see References: FAO 2004, Capua 2006). A 2005 report which evaluated the effectiveness of a vaccination campaign following an outbreak of HPAI H7N7 in chickens in the Netherlands demonstrated that vaccination was an effective strategy to reduce transmission (see References: van der Goot 2005).

In November 2005, WHO, FAO, and OIE published a document entitled Global Strategy for the Progressive Control of Highly Pathogenic Avian Influenza (see References). It includes recommendations made at the 2nd FAO/OIE Regional Meeting on Avian Influenza in Asia (Ho Chi Minh City, February 2005) and applies scientific information presented at the OIE/FAO International Scientific Conference on Avian Influenza (Paris, April 2005).

Strategies for disease control discussed in the document include:

Effective risk-based surveillance for early detection, diagnosis, and reporting
Immediate stamping out of new outbreaks when and where human life is at risk
Enhanced biosecurity of poultry farms
Control of movement of poultry and poultry products that may harbor virus, including controls at the interface of infected and uninfected areas
Rapid, humane culling of infected and "at high risk" poultry and safe disposal of carcasses
Strategic vaccination
Changes to industry practices, such as control of live bird markets and farm hygiene, to reduce risk
Separation of poultry species into "compartments"

Following outbreaks of H5N1 in poultry in Vietnam, the country took extensive measures in 2004 and 2005 to control H5N1 spread, including mandatory nationwide poultry vaccination, banning poultry rearing and live-market sales in urban areas, restricting commercial raising of ducks and quail, and imposing strict controls on poultry transport within Vietnam (see Oct 25, 2006, CIDRAP News Story). The country also initiated a broad-based public education campaign and compensates farmers (at 75% market value) whose birds need to be culled, which likely enhances reporting of infected flocks. This approach was successful in dramatically decreasing H5N1 activity and no outbreaks were reported throughout most of 2006. In December 2006, however, Vietnamese authorities reported the occurrence of several new H5N1 outbreaks, indicating that the country had failed to eliminate the H5N1 threat to its poultry industry despite extensive control measures (see Dec 20, 2006, CIDRAP News Story).

South Korea also successfully controlled a poultry outbreak of H5N1 that began in December 2003 and extended until March 2004. The government implemented strong control measures without vaccination, including culling within a 3-km radius, strict movement-control activities, disinfection, intense surveillance, and farm biosecurity. The government also compensated affected farmers 100% for lost birds (see References: WHO 2006: Influenza research at the human and animal interface). As in Vietnam, even though South Korea successfully eliminated H5N1 in 2004, in November 2006, another outbreak of H5N1 in poultry was reported from that country (see Nov 27, 2006, CIDRAP News Story).

In July 2006 WHO, FAO, and OIE announced the launch of a global early warning system for zoonoses (see References: WHO: Launch of global early warning system for animal diseases transmissible to humans). The system involves a Web-based electronic platform for international sharing of information and analysis to better detect and coordinate responses to animal diseases such as avian influenza.

In September 2006, OIE initiated the OIE/Japan Special Trust Fund Project on Avian Influenza Control in Asia, which will focus on controlling avian influenza in eight countries, including Vietnam, Lao PDR, Cambodia, Myanmar, Indonesia, Malaysia, Thailand, and the Philippines. Major activities include building laboratory diagnostic capacity, improving control strategies, developing information-sharing systems, and training field staff (see References: OIE 2006).

In November 2006, the World Bank, in collaboration with FAO, the International Food Policy Research Institute, and OIE, released the report "Enhancing control of highly pathogenic avian influenza in developing countries through compensation" (see References: World Bank 2006). Compensation of farmers may be an important factor in control of H5N1, since farmers who know they will be compensated may be more likely to report infected flocks, which can enhance detection and control efforts.

In December 2006, the World Bank indicated that it will cost between $1.2 and $1.5 billion to combat avian influenza over the next several years (see Dec 4, 2006, CIDRAP News story).

References

Al-Azemi A, Bahl J, Al-Zenki S, et al. Avian influenza A virus (H5N1) outbreaks, Kuwait, 2007. (Dispatch) Emerg Infect Dis 2008 Jun;14(6):958-61 [Full text]

APHIS (Animal and Plant Health Inspection Service) [Home page]

Bean B, Moore BM, Sterner B, et al. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982 Jul;146(1):47-51 [Abstract]

Biswas PK, Christensen JP, Ahmed SSU, et al. Avian Influenza Outbreaks in Chickens, Bangladesh. Emerg Infect Dis 2008 Dec;14(12):1909-12-8 [Full text]

Brown JD, Stallknecht, Beck JR, et al. Susceptibility of North American ducks and gulls to H5N1 highly pathogenic avian influenza viruses. Emerg Infect Dis 2006;12(11):1663-70 [Full text]

Brown JD, Goekjian G, Poulson R, et al. Avian influenza virus in water: Infectivity is dependent on pH, salinity and temperature. Vet Microbiol 2009 Apr 14;136(1-2):20-6 [Abstract]

Butler D. Alarms ring over bird flu mutations. Nature 2006 Jan 19;439:248-9 [Full text]

Capua I, Marangon S. Control of avian influenza in poultry. Emerg Infect Dis 2006;12(9):1319-24 [Abstract]

Capua I, Mutinelli F. Mortality in Muscovy ducks (Cairina moschata) and domestic geese (Anser anser vur domestica) associated with natural infection with a highly pathogenic avian influenza virus of H7Nr1 subtype. Avian Pathol 2001 Apr;30(2):179-83 [Full text]

CDC. Avian influenza A viruses [Web page]

Chaichoune K, Wirivarat W, Thitithanyanont A, et al. Indigenous sources of 2007-2008 H5N1 avian influenza outbreaks in Thailand. J Gen Virol 2009 Jan;90(1):216-22 [Abstract]

Chen H, Smith GJ, Li KS, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci 2006 Feb 21;102(8):2845-50 [Abstract]

Chen H, Smith GJ, Zhang SY, et al. Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 2005 Jul 14;436(7048):191-2 [First paragraph]

Crawford PC, Dubovi EJ, Castleman WL, et al. Transmission of equine influenza virus to dogs. Science 2005 Oct 21;310(5747):482-5 [Abstract]

Cyranoski D. Bird flu data languish in Chinese journals. (News) Nature 2004 Aug 26;430:955 [Full text]

Cyranoski D. Bird flu spreads among Java's pigs. Nature 2005 May 26;435:390-1 [Full text]

DEFRA (Department of Environment, Food, and Rural Affairs, United Kingdom). Outbreak of highly pathogenic H5N1 avian influenza in Suffolk in January 2007: a report of the epidemiological findings by the National Emergency Epidemiology Group, DEFRA. Final report Nov 2007 [Full text]

Ducatez MF, Olinger CM, Owoade AA, et al. Avian flu: multiple introductions of H5N1 in Nigeria. Nature 2006 Jul 6;442(7098):37 [Abstract]

European Centre for Disease Prevention and Control Influenza Team. H5N1 infections in cats: public health implications. Eurosurveillance Weekly 2006 Apr 13;11(4):pii=2942 [Full text]

European Centre for Disease Surveillance and Control Influenza Team. World avian influenza update: H5N1 could become endemic in Africa. Eurosurveillance Weekly 2006 Jun 22:11(6):pii=2979 [Full text]

FAO. Avian influenza control and eradication: FAO's proposal for a global programme. Mar 2006 [Full text]

FAO. Avian influenza in cats should be closely monitored. Feb 8, 2007 [Full text]

FAO. Caucasus, Balkans at high risk for deadly H5N1 virus. Aug 21, 2006 [Full text]

FAO. Evolution of highly pathogenic avian influenza type H5N1 in Europe: review of disease ecology, trends, and perspectives of spread autumn-winter 2006. EMPRES Watch 2006 Oct [Full text]

FAO. H5N1 HPAI global overview: May 2008. FAO AIDEnews 2008 Jun 16; Situation Update 54 [Full text]

FAO. Recommendations on the prevention, control, and eradication of highly pathogenic avian influenza (HPAI) in Asia. Sep 2004 [Full text]

FAO. Should wild birds now be considered a permanent reservoir of the virus? FAO AIDEnews 2006 Jun 19, issue No. 40 [Full text]

FAO. Fewer bird flu outbreaks this year—sign of progress, FAO says. Avian influenza still threatens people’s lives and economies. Apr 2, 2007 [Full text]

FAO. Vietnam: H5N1 HPAI pathogenicity rising, but situation in check. FAO AIDEnews 2008 Jul 25, Issue No. 55 [Full text]

FAO/OIE/WHO. A global strategy for the progressive control of highly pathogenic avian influenza (HPAI), Nov 2005 [Full text]

FAO/OIE/WHO. Consultation on avian influenza and human health: risk reduction measures in producing, marketing, and living with animals in Asia. Kuala Lumpur, Malaysia. Jul 2005 [Full text]

FAO/OIE/WHO. Joint warning: domestic ducks could pose a new Avian influenza threat. Nov 11, 2004 [Full text]

Fasina FO, Bisschop SP, Joannis TM, et al. Molecular characterization and epidemiology of the highly pathogenic avian influenza H5N1 in Nigeria. Epidemiol Infect 2008 (published online Jul 17) [Abstract]

Fouchier RAM, Schneeberger PM, Rozendaal FW, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci 2004. Published online before print January 26, 2004 [Abstract]

Fouchier RAM, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls J Virol 2005 Mar;79(5):2814-22 [Abstract]

Ge J, Deng G, Wen Z, et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N2 avian influenza viruses. J Virol 2007 Jan;81(1):150-8 [Abstract]

Gilbert M, Chaitaweesub P, Parakamawongsa T, et al. Free-grazing ducks and highly pathogenic avian influenza, Thailand. Emerg Infect Dis 2006 Feb;12(2):227-34 [Abstract]

Gilbert M, Xiao S, Domenech J, et al. Anatidae migration in the western palearctic and spread of highly pathogenic avian influenza H5N1 virus. Emerg Infect Dis Nov 2006;12(11):1650-6 [Full text]

Gilsdorf A, Boxall N, Gasimov V, et al. Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006. Eurosurveillance Monthly 2006 May 1;11(5):pii=620 [Full text]

Hall JS, Bentler KT, Landolt G, et al. Influenza infection in wild raccoons. Emerg Infect Dis 2008 Dec;14(12):1842-8 [Full text]

Horimoto T, Kawaoka Y. Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev 2001;14(1):129-49 [Abstract]

Kahn CM, ed. Influenza: Introduction. In: Merck veterinary manual. Ed 9. Whitehouse Station, NJ: Merck & Co, 2008 [Full text]

Kalthoff D, Hoffmann B, Harder T, et al. Experimental infection of cattle with highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2008;14(7) July:1132-4 [Full text]

Keawcharoen J, Oraveerakul K, Kuiken T, et al. Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004 Dec;10(12):2189-91 [Full text]

Kilpatrick AM, Chmura AA, Gibbons DW, et al. Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci 2006 Dec 19;103(51):19368-73 [Abstract]

Kiss I, Gyarmati P, Zohari S, et al. Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006. Virol J 2008 Oct 6;5(1):113 [Full text]

Komar N, Olsen B. Avian Influenza Virus (H5N1) Mortality Surveillance. (Letter) Emerg Infect Dis 2008 Jul;14(7):1176-8 [Full text]

Kou Z, Lei FM, Yu J, et al. New genotype of avian influenza H5N1 viruses isolated from tree sparrows in China. J Virol 2005 Dec;79(24):15460-6 [Abstract]

Kung NY, Morris RS, Perkins NR, et al. Risk for infection with higly pathogenic influenza A virus (H5N1) in chickens, Hong Kong, 2002. Emerg Infect Dis 2007:13(3):412-8 [Full text]

Lee CW, Senne DA, Suarez DL, et al. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 2004 Aug;78:8372-81 [Abstract]

Leschnik M, Weikel J, Mosti K, et al. Subclinical infection with avaian influenza A (H5N1) virus in cats. Emerg Infect Dis 2007 Feb;13(2):243-7 [Full text]

Li Z, Jiang Y, Jiao P, et al. The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J Virol 2006;80(22):11115-23 [Abstract]

Lipatov AS, Kwon YK, Sarmento LV, et al. Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog 2008 Jul 11;4(7):e1000102 [Abstract]

Liu J, Xiao H, Lei F, et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. (Brevia) Science 2005 Aug 19;309(5738):1206 [Full text]

Luschow D, Werner O, Mettenleiter TC, et al. Protections of chickens from lethal avian influenza A virus infections by live-virus hemagglutinin (H5) gene. Vaccine 2001 Jul 20;19(30):4249-59 [Abstract]

Monto AS. The threat of an avian influenza pandemic. (Perspective) N Engl J Med 2005 Jan 27;352(4):323-4 [Full text]

OIE. Evolution of the animal health situation with regard to avian influenza. Aug 29, 2005 [Full text]

OIE. Avian influenza. In: Terrestrial animal health code. Chap 10.4. 2008 [Full text]

OIE. Highly pathogenic avian influenza. Technical disease card database. Apr 22, 2002 [Web page]

OIE. Manual of diagnostic tests and vaccines for terrestrial animals: avian influenza. Chap 2.3.4. Jul 2008 [Full text]

OIE. Implementing the OIE/Japan Special Trust Fund Project on Avian Influenza Control in Asia. Sep 25, 2006 [Press release]

OIE. Update on avian influenza in animals in Asia (type H5 and H7) [Web page]

Olsen B, Munster VJ, Wallensten A, et al. Global patterns of influenza A virus in wild birds. Science 2006 Apr 12;312:384-8 [Full text]

Owoade AA, Gerloff NA, Ducatez MF, et al. Highly pathogenic avian influenza (H5N1), sub-Saharan Africa. Emerg Infect Dis 2008 Nov;14(11):1731-5 [Full text]

Park MS, Steel J, Garcia-Sastre A, et al. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci 2006 May 23;103(21):8203-8 [Full text]

PHS (Poultry Health Services). Fowl plague, avian influenza highly pathogenic. PHS Avian Influenza Forum [Web page]

Rappole JH, Hubalek Z. Birds and influenza H5N1 virus movement to and within North America. (Perspective) Emerg Infect Dis 2006;12(10):1486-92 [Full text]

Reperant LA, van Amerongen G, van de Bildt MWG, et al. Highly pathogenic avian influenza virus (H5N1) infection in red foxes fed infected bird carcasses. Emerg Infect Dis 2008 Dec;14(12):1835-41 [Full text]

Rimmelzwaan GF, van Riel D, Baars M, et al. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 2006:168:176-83 [Abstract]

Senne DA, Suarez DL, Stallnecht DE, at al. Ecology and epidemiology of avian influenza in North and South America. Dev Biol (Basel) 2006;124:37-44 [Abstract]

Shestopalov AM, Durimanov AG, Evseenko VA, et al. H5N1 influenza virus, domestic birds, western Siberia, Russia. (Letter) Emerg Infect Dis 2006 Jul;12(7):1167-8

Smith, GJ, Fan XH, Wang J, et al. Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci 2006;103(45):16936-41 [Abstract]

Snaken R, Kendal AP, Haaheim LR, et al. The next influenza pandemic: lessons from Hong Kong, 1997. Emerg Infect Dis 1999;5(2):195-203 [Full text]

Songserm T, Amonsin A, Jam-on R, et al. Avian influenza H5N1 in naturally infected domestic cat. Emerg Infect Dis 2006 Apr;12(4):681-3 [Abstract]

Songserm T, Amonsin A, Jam-on R, et al. Fatal avian influenza A H5N1 in a dog. Emerg Infect Dis 2006 Nov;12(11):1744-7 [Full text]

Stallknecht DE. Shane SM, Kearney MT, et al. Persistence of avian influenza virses in water. Avian Dis 1990 Apr-Jun;34(2):406-11 [Abstract]

Stegeman A, Bouma A, Elbers ARW, et al. Avian influenza A virus (H7N7) epidemic in The Netherlands in 2003: course of the epidemic and effectiveness of control measures. J Infect Dis 2004 Dec 15;190:2088-95 [Abstract]

Steensels M, Bublot M, Van Borm S, et al. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI. Vaccine 2008 (Published online Dec 3) [Abstract]

Stohr K. Avian influenza and pandemics research needs and opportunities. (Editorial) N Engl J Med 2005 Jan 27;352(4):405-07 [Extract]

Swayne DE. Avian influenza. In: US Animal Health Association, Committee on Foreign and Emerging Diseases. Foreign animal diseases (the gray booka). Ed 7. 2008. Part III, chap 5:137-46; photos:441-2 [Full text]

Tiensin T, Chaitaweesub P, Songserm T, et al. Highly pathogenic avian influenza H5N1, Thailand 2004. Emerg Infect Dis 2005 Nov;11(11):1664-72 [Abstract]

Thanawongnuwech R, Amonsin A, Tantilertcharoen R, et al. Probable tiger-to-tiger transmission of avian influenza H5N1. Emerg Infect Dis 2005 May;11(5):699-701 [Abstract]

Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. (Letter) Nature 2005;437(7060):889-93 [Full text]

USDA. Avian influenza [Web page]

USGS National Wildlife Health Center. List of species affected by H5N1 [Web page]

USGS National Wildlife Health Center. National HPAI Early Detection Data System (HEDDS) [Web page]

Uyeki TM, Chong YH, Katz JM, et al. Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China, 1999. Emerg Infect Dis 2002 Feb;8(2):154-9 [Full text]

Van Born S, Thomas I, Hanquet G, et al. Highly pathogenic H5N1 influenza virus in smuggled Thai Eagles, Belgium. Emerg Infect Dis 2005 May;11(5):702-5 [Abstract]

Van der Goot JA, Koch G, de Jong MCM, et al. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc Natl Acad Sci 2005 Dec 13;102(50):18141-6 [Abstract]

Veits J, Wiesner D, Fuchs W, et al. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci 2006 May 23;103(21):8197-202 [Abstract]

Vong S, Ly S, Mardy S, et al. Environmental contamination during influenza A virus (H5N1) outbreaks, Cambodia, 2006. Emerg Infect Dis 2008 Aug;14(8):1303-5 [Full text]

Voyles BA. Orthomyxoviruses. In: The biology of viruses. Ed 2. New York, NY: McGraw-Hill, 2002:147

Wallace RG, HoDac HM, Lathrop RH, et al. A statistical phylogeography of influenza A H5N1. Proc Natl Acad Sci 2007 Mar 13;104(11):4473-8 [Abstract]

Wan H, Sorrell EM, Song H, et al. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS One 2008 Aug;3(8):1-13 [Full text]

Webster RG, Yakhno M, Hinshaw VS, et al. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 1978;84(2):268-78 [Abstract]

Webster RG, Bean WJ, Gorman OT, et al. Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-79 [Abstract]

Webster RG, Peiris M, Chen H, et al. H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 2006 Jan;12(1):3-8 [Abstract]

Winker K, Spackman E, Swayne DE. Rarity of influenza A virus in spring shorebirds, southern Alaska. Emerg Infect Dis;14(8) Aug 2008:1314-15 [Full text]

WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines. [Full text]

WHO. Avian influenza: situation (birds) in Nigeria. Feb 8, 2006 [Full text]

WHO. Cumulative confirmed human cases of H5N1 avian influenza [Web page--open most recent report available]

WHO. Epidemic and pandemic alert and response (EPR)

WHO. Geographical spread of H5N1 avian influenza in birds: update 28 [Full text]

WHO. H5N1 avian influenza: timeline of major events. Nov 7, 2011 [Full text]

WHO. Influenza pandemic preparedness and response. Jan 20, 2005 [Full text]

WHO. Influenza research at the human and animal interface. Report of a WHO Working Group. Released Nov 1, 2006 [Full text]

WHO. Laboratory study of H5N1 viruses in domestic ducks: main findings. Oct 29, 2004

WHO. Launch of global early warning system for animal diseases transmissible to humans. Jul 24, 2006 [Press release]

WHO. Review of latest available evidence on risks to human health through potential transmission of avian influenza (H5N1) through water and sewage. [Full text]

WHO Global Influenza Program Surveillance Network. Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005 Oct 11(10):1515-21 [Abstract]

World Bank. Enhancing control of highly pathogenic avian influenza in developing countries through compensation. Nov 27, 2006 [Full text]

Worobey M. Phylogenetic evidence against evolutionary stasis and natural abiotic reservoirs of influenza A virus. J Virol 2008 Apr;82(7):3769-74 [Full text]

Yamamoto Y, Nakamura K, Okamatsu M, et al. Detecting avian influenza virus (H5N1) in domestic duck feathers. (Letter) Emerg Infect Dis 2008 Oct;14(10):1671-2 [Full text]

Yingst SL, Saad MD, Felt SA. Qinghai-like H5N1 from domestic cats, Northern Iraq. (Letter) Emerg Infect Dis 2006 Aug;12(8)

Yoon KJ, Cooper VL, Schwartz KJ, et al. Influenza virus infection in racing greyhounds. Emerg Infect Dis 2005 Dec;11(12):1974-5

Zhang G, Shoham D, Gilichinsky D, et al. Evidence of influenza A virus RNA in Siberian lake ice. J Virol 2006 Dec;80(24):12229-35 [Abstract]


Home	Mission & Activities	About Us	Center Support	Contact Us